Giorgio Dell’Acqua

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

Michael J. Mann, Anthony D. Whittemore, Magruder C. Donaldson et al. · The Lancet · 1999 · 400 citations

Translational Medicine, Gene Therapies, Transplantation +13

Gene Therapy Strategy for Long-Term Myocardial Protection Using Adeno-Associated Virus-Mediated Delivery of Heme Oxygenase Gene

Luis G. Melo, Reitu S. Agrawal, Lunan Zhang et al. · Circulation · 2002 · 303 citations

Use of the Quorum‐Sensing Inhibitor RNAIII‐Inhibiting Peptide to Prevent Biofilm Formation In Vivo by Drug‐Resistant<i>Staphylococcus epidermidis</i>

Naomi Balaban, Oscar Cirioni, Yael Gov et al. · The Journal of Infectious Diseases · 2003 · 168 citations · Full text

Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy

Afshin Ehsan, Michael J. Mann, Giorgio Dell’Acqua et al. · Journal of Thoracic and Cardiovascular Surgery · 2001 · 135 citations · Full text

Thrombosis, Vascular Disease, Long-term Stabilization +11

RNA III Inhibiting Peptide Inhibits In Vivo Biofilm Formation by Drug-Resistant <i>Staphylococcus aureus</i>

Oscar Cirioni, Yael Gov, Roberto Ghiselli et al. · Antimicrobial Agents and Chemotherapy · 2003 · 119 citations · Full text